Cai Q, Zhang X, Chen H (2021) Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review. Thromb J 19(1):93. https://doi.org/10.1186/s12959-021-00345-z

Article  CAS  Google Scholar 

Hawryluk GW, Furlan JC, Austin JW, Fehlings MG (2011) Survey of neurosurgical management of central nervous system hemorrhage in patients receiving anticoagulation therapy: current practice is highly variable and may be suboptimal. World Neurosurg 76(3–4):299–303. https://doi.org/10.1016/j.wneu.2011.03.034

Article  Google Scholar 

Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH (2014) Benefits and risks of anticoagulation resumption following traumatic brain injury. JAMA Intern Med 174(8):1244–1251. https://doi.org/10.1001/jamainternmed.2014.2534

Article  Google Scholar 

Matsushima K, Inaba K, Cho J, Mohammed H, Herr K, Leichtle S, Zada G, Demetriades D (2016) Therapeutic anticoagulation in patients with traumatic brain injury. J Surg Res 205(1):186–191. https://doi.org/10.1016/j.jss.2016.06.042

Article  Google Scholar 

Puckett Y, Zhang K, Blasingame J, Lorenzana J, Parameswaran S, Brooks SE, Baronia BC, Griswold J (2018) Safest time to resume oral anticoagulation in patients with traumatic brain Injury. Cureus 10(7):e2920. https://doi.org/10.7759/cureus.2920

Article  Google Scholar 

Tykocki T, Guzek K (2016) Anticoagulation Therapy in Traumatic Brain Injury. World Neurosurg 89:497–504. https://doi.org/10.1016/j.wneu.2016.01.063

Article  Google Scholar 

Hawryluk GW, Austin JW, Furlan JC, Lee JB, O’Kelly C, Fehlings MG (2010) Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 8(7):1500–1508. https://doi.org/10.1111/j.1538-7836.2010.03882.x

Article  CAS  Google Scholar 

van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ et al (2015) Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial. Trials 16:393. https://doi.org/10.1186/s13063-015-0898-4

Article  CAS  Google Scholar 

Diringer MN, Bleck TP, Claude Hemphill J 3rd et al (2011) Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15(2):211–240. https://doi.org/10.1007/s12028-011-9605-9

Carney N, Totten AM, O’Reilly C et al (2017) Guidelines for the management of severe traumatic brain Injury, Fourth Edition. Neurosurgery 80(1):6–15. https://doi.org/10.1227/NEU.0000000000001432

Article  Google Scholar 

Kahn SR, Lim W, Dunn AS et al (2012) Prevention of VTE in nonsurgical patients: antithrombotic therapy and Prevention of thrombosis, 9th ed: american college of chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e195S–e226. https://doi.org/10.1378/chest.11-2296

Article  CAS  Google Scholar 

Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (6 Suppl):381S-453S. https://doi.org/10.1378/chest.08-0656

Hemphill JC, Greenberg SM, Anderson CS et al (2015) Guidelines for the management of spontaneous intracerebral hemorrhage: a Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke 46(7):2032–2060. https://doi.org/10.1161/STR.0000000000000069

Article  Google Scholar 

Steiner T, Kaste M, Forsting M et al (2006) Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The european Stroke Initiative writing Committee and the writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 22(4):294–316. https://doi.org/10.1159/000094831

Article  Google Scholar 

Nguyen NY, Frishman WH (2020) Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage. Cardiol Rev 2020;28(4):190–196. https://doi.org/10.1097/CRD.0000000000000288

Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY (2015) Restarting anticoagulant treatment after Intracraniala Hemorrhage in patients with Atrial Fibrillation and the impact on recurrent stroke, mortality, and bleeding: a Nationwide Cohort Study. Circulation 132(6):517–525. https://doi.org/10.1161/CIRCULATIONAHA.115.015735

Article  CAS  Google Scholar 

Ottosen TP, Grijota M, Hansen ML et al (2016) Use of Antithrombotic Therapy and Long-Term Clinical Outcome among Patients surviving Intracerebral Hemorrhage. Stroke 47(7):1837–1843. https://doi.org/10.1161/STROKEAHA.116.012945

Article  CAS  Google Scholar 

Byrnes MC, Irwin E, Roach R, James M, Horst PK, Reicks P (2012) Therapeutic anticoagulation can be safely accomplished in selected patients with traumatic intracranial hemorrhage. World J Emerg Surg 7(1):25. https://doi.org/10.1186/1749-7922-7-25

Article  Google Scholar 

Appendix C: VTE Measurement and Tracking. Content last reviewed May 2016. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/patient-safety/resources/vtguide/appc.html

The Joint Commission (2018) Specifications Manual for Joint Commission National Quality Measures – Modified Rankin Score (mRS). Accessed September 7, 2021. https://manual.jointcommission.org/releases/TJC2018A/DataElem0569.html

Bailey RD, Hart RG, Benavente O, Pearce LA (2001) Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56:773–777. https://doi.org/10.1212/WNL.56.6.773

Passero S, Burgalassi L, D’andrea P, Battistini N (1995) Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 26:1189–1192. https://doi.org/10.1161/01.STR.26.7.1189

Cosgrove GR, Leblanc R, Meagher-Villemure K, Ethier R (1985) Cerebral amyloid angiopathy. Neurology 35:625–631. https://doi.org/10.1212/WNL.35.5.625

Kearon C, Akl EA, Ornelas J, (2016) Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest 149(2):315–352. https://doi:https://doi.org/10.1016/j.chest.2015.11.026

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921), 955–962. https://doi.org/10.1016/S0140-6736(13)62343-0

Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138(5):1093–1100. https://doi:https://doi.org/10.1378/chest.10-0134

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137(2):263–272. https://doi:https://doi.org/10.1378/chest.09-1584